LICENSE AGREEMENT BY AND BETWEEN JANSSEN PHARMACEUTICA NV AND PIPELINE THERAPEUTICS, INC. Dated February 3, 2023License Agreement • December 13th, 2023 • Contineum Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledDecember 13th, 2023 Company Industry JurisdictionThis License Agreement (this “Agreement”) is entered into as of February 3, 2023 (the “Execution Date”) by and between Pipeline Therapeutics, Inc., a Delaware corporation (“Licensor”), on the one hand, and Janssen Pharmaceutica NV, a Belgium company (“Janssen”), on the other hand. Licensor and Janssen are referred to in this Agreement each individually as a “Party” and collectively as the “Parties.”